Consensus AstraZeneca PLC

Equities

AZN

GB0009895292

Market Closed - London S.E. 11:35:17 2024-04-12 EDT 5-day change 1st Jan Change
11,064 GBX +0.93% Intraday chart for AstraZeneca PLC +4.18% +4.38%

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

d50a43a8a4eb90e3e0970a6afdd5e45.Ps0WG2XiwBJborsnoJZqxtETffJabJrmjW6xepcsPk0.DaVTaUiytGMi-v509MYYouFZObhiDqyz4R2JOaVHDwJOjmNPP7afaCHn9g~fceac42d00d9ae167a3f9148b66bf0d2
Fitch Affirms AstraZeneca Rating on Stable Position in Pharmaceutical Sector MT
Shareholder Says AstraZeneca CEO 'Massively Underpaid' MT
ASTRAZENECA : Gets a Buy rating from Barclays ZD
ASTRAZENECA : Gets a Sell rating from UBS ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating ZD
ASTRAZENECA : JP Morgan keeps its Buy rating ZD
ASTRAZENECA : AstraZeneca should not be overlooked for long Alphavalue
Bernstein Starts AstraZeneca Coverage at Outperform MT
Bernstein starts AstraZeneca at 'outperform' AN
Advisers Urge Shareholders to Vote Against AstraZeneca CEO's Pay Plan MT
ASTRAZENECA : Deutsche Bank reiterates its Sell rating ZD
ASTRAZENECA : Gets a Sell rating from UBS ZD
B. Riley Downgrades Fusion Pharmaceuticals to Neutral From Buy on Heels of Announced Sale to AstraZeneca, Adjusts PT to $23 From $13 MT
Fusion Pharmaceuticals Downgraded by RBC to Sector Perform From Outperform, Speculative Risk Removed, Price Target Raised to $21 From $16 MT
ASTRAZENECA : UBS reaffirms its Sell rating ZD
ASTRAZENECA : Deutsche Bank keeps a Sell rating ZD
ANALYST RECOMMENDATIONS : Abbvie, Align Technology; Ulta Beauty, United Airlines, Currys... Our Logo
ASTRAZENECA : Buy rating from JP Morgan ZD
Berenberg: AstraZeneca Set for More Lung Cancer Success After Recent Pipeline Gains MT
ASTRAZENECA : Deutsche Bank reiterates its Sell rating ZD
Berenberg Trims AstraZeneca PT, Maintains Buy Rating MT
JPMorgan cuts Airtel Africa price target by 28% AN
ASTRAZENECA : Berenberg reiterates its Buy rating ZD
ASTRAZENECA : UBS keeps a Sell rating ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
137.7 USD
Average target price
162 USD
Spread / Average Target
+17.60%
High Price Target
222.2 USD
Spread / Highest target
+61.32%
Low Price Target
119.9 USD
Spread / Lowest Target
-12.91%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

BARCLAYS Emily Field
JPMORGAN James Gordon
UBS Matthew Weston
alphavalue Abhishek Raval
Bernstein
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
B. Riley
RBC Capital Markets
Berenberg Bank
BERENBERG Luisa Hector
JEFFERIES Peter Welford
DZ Bank
BMO Capital
Stifel Nicolaus
Deutsche Bank Securities
Jefferies & Co.
CREDIT SUISSE Dominic Lunn
HSBC
Argus
Morgan Stanley
GOLDMAN SACHS Keyur Parekh
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA) Sachin Jain
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. AZN Stock
  4. Consensus AstraZeneca PLC